Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Loss-making Dade Behring plans to shed low profile and improve communications in its "investment year"

This article was originally published in Clinica

Executive Summary

Dade Behring, which has a unique position among big company laboratory diagnostics companies in that it is effectively privately-owned, is to abandon its policy of reticence in communicating with the outside world. It even concedes that its communications with its small, core group of bondholders - institutions that have invested in Dade Behring's debt - have not hitherto been good.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076958

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel